GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE5122 Query DataSets for GSE5122
Status Public on Jan 31, 2007
Title Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory AML
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Gene signatures were derived to separate responders from nonresponders by tipifarnib treatment.
Keywords: response analysis
Overall design 58 samples from 58 patients
Citation(s) 17404110
Submission date Jun 21, 2006
Last update date Aug 10, 2018
Contact name Jack Yu
Phone 858-320-3362
Fax 858-784-3182
Organization name Veridex, LLC
Street address 3210 Merryfield Row
City San Diego
State/province CA
ZIP/Postal code 92121
Country USA
Platforms (1)
GPL96 [HG-U133A] Affymetrix Human Genome U133A Array
Samples (58)
GSM115698 A30009
GSM115699 A30011
GSM115700 A30059
BioProject PRJNA96619

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE5122_ClinicalInfo.pdf 38.0 Kb (ftp)(http) PDF

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap